{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T14:33:49Z","timestamp":1770647629103,"version":"3.49.0"},"reference-count":0,"publisher":"Wiley","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pharmacol Ther"],"published-print":{"date-parts":[[1991,6]]},"DOI":"10.1038\/clpt.1991.77","type":"journal-article","created":{"date-parts":[[2010,8,30]],"date-time":"2010-08-30T13:08:09Z","timestamp":1283173689000},"page":"609-617","source":"Crossref","is-referenced-by-count":93,"title":["Role of P450IID6, the target of the sparteine-debrisoquin oxidation polymorphism, in the metabolism of imipramine"],"prefix":"10.1111","volume":"49","author":[{"given":"Kim","family":"Br\u00f8sen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanja","family":"Zeugin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urs A","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","container-title":["Clinical Pharmacology and Therapeutics"],"original-title":[],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T13:17:46Z","timestamp":1699363066000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1038\/clpt.1991.77"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,6]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1991,6]]}},"alternative-id":["clpt199177"],"URL":"https:\/\/doi.org\/10.1038\/clpt.1991.77","relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,6]]}}}